News search
Research 4 Feb 2025 The study, published in JACC: CardioOncology, shows that administration of the SGLT2 inhibitor empagliflozin to pigs receiving anthracyclines preserves mitochondrial function, improves myocardial energetics, and prevents degenerative changes in heart structure |
Research 12 Dec 2024 iFlpMosaics is a new technology presented in Nature Methods that allows the modification and study of gene function in mouse models, advancing research on diseases caused by somatic mutations, such as cancer and vascular malformations. |
About the CNIC 12 Dec 2024 The new project, ‘The Placenta in Maternal and Fetal Cardiovascular Health and Disease’, aims to understand how the placenta influences cardiovascular health in mothers and their children, promising improvements in the prevention and treatment of related diseases |
About the CNIC 11 Dec 2024 |
Research 29 Jul 2024 A study by the CNIC and Fundación SHE, supported by “la Caixa” Foundation, demonstrates that schools are a crucial environment for health promotion in children |
About the CNIC 11 Jun 2024 iSuRe-HadCre promises to become an essential tool for biomedical research using mouse models to modify and understand gene function |
About the CNIC 17 May 2024 |
About the CNIC 15 May 2024 Globally, cardiovascular diseases due to atherosclerosis – the build-up of plaque in arteries – are the leading cause of death. A new Danish-Spanish research collaboration aims to develop methods to detect atherosclerosis at earlier ages and encourage prevention. Denmark’s Novo Nordisk Foundation has granted up to EUR 23 million to cover the first 2.5 years of the REACT initiative. The initiative is expected to run for 8 years in total |
- 1 of 17
- next ›